Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 2054702Erstellt: 26. Oktober 2026

Isradipine → 2-Acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester

https://huagongshe.com/reaction/2054702

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktIsradipineHCID 3784—
EduktMethyl acetoacetateHCID 7757—
EduktPiperidineHCID 8082—
Edukt2,1,3-Benzoxadiazole-4-carbaldehydeHCID 10290873—
LösungsmittelAcetic AcidHCID 176—
LösungsmittelDiisopropyl EtherHCID 7914—
Produkt2-Acetyl-3-benzofurazan-4-yl-acrylic acid methyl esterHCID 53433213—

Reaktionsschritte

To achieve the afore-mentioned objects, the present invention provides for a process for the manufacture of the Isradipine which, involves two steps. In the first step 2,1,3-benzoxadiazole-4-carboxaldehyde is reacted with methyl acetoacetate in the presence of acetic acid and piperidine in diisopropyl ether. The product 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester is isolated and purified to get substantially high purity product with less than 0.3% 2,1,3-benzoxadiazole-4-carboxaldehyde content present in the purified product. In the second step the purified intermediate 2-acetyl-3-benzofurazan-4-yl-acrylic acid methyl ester is reacted with isopropyl-β-aminocrotonate in ethanol at 25 to 35° C. The crude Isradipine is crystallised from ethanol to get pure Isradipine having substantially higher purity and containing lower amount of the symmetrical ester isomers (III) and (IV).

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS07329756B2
Quelldatensatzuspto-grants-2008_02
ORD IDord-391dc78fba9444bda56964b252ebf9ae
Quellennotizuspto-grants-2008_02